We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,652 results
  1. Effects of pasteurization on osteopontin concentrations in human breastmilk

    Background

    Osteopontin (OPN) is an important breastmilk protein involved in infant intestinal, immunological, and brain development. However, little...

    Kathleen G. McClanahan, Jeff Reese, ... Danyvid Olivares-VillagĆ³mez in Pediatric Research
    Article 13 October 2023
  2. Osteopontin: A Novel Therapeutic Target for Respiratory Diseases

    Osteopontin (OPN) is a multifunctional phosphorylated protein that is involved in physiological and pathological events. Emerging evidence suggests...

    Qi Jia, Yeling Ouyang, ... Zhiqiang Hu in Lung
    Article 07 December 2023
  3. Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis

    Background

    Anti-citrullinated protein/peptide antibodies (ACPAs) are present in patients at onset and have important pathogenic roles during the...

    Akio Umemoto, Takeshi Kuwada, ... Shuichi Matsuda in Arthritis Research & Therapy
    Article Open access 17 February 2023
  4. Osteopontin promotes infarct repair

    Understanding how macrophages promote myocardial repair can help create new therapies for infarct repair. We aimed to determine what mechanisms...

    Itai Rotem, Tal Konfino, ... Jonathan Leor in Basic Research in Cardiology
    Article 14 October 2022
  5. Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms

    Purpose

    Osteopontin (OPN), also called secreted phosphoprotein 1 (SPP1) is a matricellular glycoprotein whose expression is elevated in various types...

    Evelyn Kidess, Yvonne Giesecke, ... Michael Sigal in Journal of Cancer Research and Clinical Oncology
    Article Open access 15 June 2023
  6. Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

    Purpose

    Pembrolizumab-based regimens are conditioned by the expression of PD-L1, but durable response rate is limited by innate and acquired...

    Davide Ramoni, Simona Coco, ... Federico Carbone in Lung
    Article Open access 13 March 2024
  7. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the bloodā€“brain barrier in acute ischemic stroke

    Bloodā€“brain barrier (BBB) dysfunction, characterized by degradation of BBB junctional proteins and increased permeability, is a crucial...

    Daniel Spitzer, Sylvaine GuƩrit, ... Kavi Devraj in Acta Neuropathologica
    Article Open access 25 June 2022
  8. A case of neurodegenerative Langerhans cell histiocytosis exhibiting high osteopontin in cerebrospinal fluid without specific radiological abnormalities

    Neurodegenerative Langerhans cell histiocytosis (ND-LCH) manifests several years after onset of LCH, with progressive neurological symptoms and...

    Yuta Sakai, Yasuhiro Ikawa, ... Taizo Wada in International Journal of Hematology
    Article 31 July 2023
  9. Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

    Background

    Combination therapy with anti-programmed death-ligand 1 and anti-vascular endothelial growth factor (VEGF) antibodies has become the...

    Reika Yamauchi, Takanori Ito, ... Tatsuya Kanto in Journal of Gastroenterology
    Article 30 March 2023
  10. IER2-induced senescence drives melanoma invasion through osteopontin

    Expression of the immediate-early response gene IER2 has been associated with the progression of several types of cancer, but its functional role is...

    Lenka Kyjacova, Rafael Saup, ... Jonathan P. Sleeman in Oncogene
    Article Open access 05 October 2021
  11. Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease

    Background

    First-degree relatives (FDRs) of rheumatoid arthritis (RA) patients are known to have increased risk of develo** the disease. The...

    Eiman Soliman, Sarah Ohrndorf, ... Abeer Abdelati in BMC Musculoskeletal Disorders
    Article Open access 05 March 2024
  12. Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model

    Clonal myeloproliferation and development of bone marrow (BM) fibrosis are the major pathogenetic events in myelofibrosis (MF). The identification of...

    Elisa Bianchi, Sebastiano Rontauroli, ... Rossella Manfredini in Leukemia
    Article Open access 16 March 2023
  13. The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery

    Background/Aim

    Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and...

    Kumiko Sekiguchi, Akihisa Matsuda, ... Hiroshi Yoshida in International Journal of Clinical Oncology
    Article 11 August 2022
  14. Reliability, stability during long-term storage, and intra-individual variation of circulating levels of osteopontin, osteoprotegerin, vascular endothelial growth factor-A, and interleukin-17A

    Background

    Studies in many populations have reported associations between circulating cytokine levels and various physiological or pathological...

    Tomoki Nakamizo, John Cologne, ... Waka Ohishi in European Journal of Medical Research
    Article Open access 17 February 2024
  15. Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease

    Background

    Osteoprotegerin (OPG) and osteopontin (OPN) are vascular calcification inhibitors with a known role in the atherosclerotic and inflammatory...

    Nikolaos P. E. Kadoglou, Dimitrios Kapetanios, ... Christos Karkos in Cardiovascular Diabetology
    Article Open access 01 September 2022
  16. Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process

    Objective

    This study aimed to investigate the effects of sex hormone imbalance on rat prostatic inflammation and fibrosis and identify the key...

    Ying Cao, Heng Zhang, ... Lei Tang in International Urology and Nephrology
    Article 09 March 2023
  17. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway

    Purpose

    Triple-negative breast cancer (TNBC) features high aggressiveness, metastasis rate, drug resistance as well as poor prognosis. Osteopontin...

    Man Guo, Mengyue Liu, ... Hao Zhang in Journal of Cancer Research and Clinical Oncology
    Article Open access 25 March 2024
  18. Osteopontinā€induced lncRNA HOTAIR expression is involved in osteoarthritis by regulating cell proliferation

    Background

    Osteopontin plays critical roles in osteoarthritis (OA) by regulating the functions of osteoclasts. It is known that osteopontin can induce...

    Quanzhi Liang, Ailijiang Asila, ... Rui Fang in BMC Geriatrics
    Article Open access 14 January 2021
  19. Plasmatic osteopontin and vascular access dysfunction in hemodialysis patients: a cross-sectional, caseā€“control study (The OSMOSIS Study)

    Background and aims

    Despite close follow-up of patients with native arteriovenous fistulas (AVFs), up to 10% experience thrombosis each year. The...

    Julie Contenti, Matthieu Durand, ... Nirvana Sadaghianloo in Journal of Nephrology
    Article 01 September 2021
Did you find what you were looking for? Share feedback.